Insight & Updates

Insights & Updates

Insights, Research & Industry Updates

PAH using F18-FBB for cardiac amyloidosis

New Radiochemical Lab to Support Next-Gen Cancer Treatment

Cyclotek Awarded CRC-P Round 16 Grant to Advance Nanobody-Based Theranostic Platform for Cancer

Cyclotek Enables First in Human Company-Sponsored Trial with Terbium-161 Radiopharmaceutical in Australia

Cyclotek and the University of Melbourne sign Strategic Partnership Agreement

Cyclotek lends a hand in PSMA-PET in Active Surveillance for Ca Prostate

Cyclotek supports Macquarie University’s Research Studies in Motor Neuron Disease (MND)

Neuroinflammation as a Mechanism, Biomarker, and Therapeutic Target in Degenerative Brain Disorders

ASAN Medical Centre and Duchembio, Korea, licence DAT PET tracer for Parkinson’s to Cyclotek